News

Achillion Pharmaceuticals, a US-based biopharmaceutical company has announced that the US Patent & Trademark Office has granted Achillion a US patent related to the company’s NS4A antagonists to

Mednax, a provider of neonatal, maternal-fetal and pediatric physician services, has implemented Courion’s Enterprise Suite to assure access to critical systems and data for its approximately 5,000 clinical

The department’s online resource titled: “Genetic Evaluation and Testing for Hereditary Colorectal Cancer: What You Should Know.” The resource provides answers to many questions such as: How often

Complete first quarter 2009 unaudited interim financial results are anticipated to be released on May 15, 2009. “Our exceptional performance this quarter shows that our strategy is working,”

MacuSight team has selected the etrials solutions for not only its functionality, but also its client teams who would be implementing these systems as an integral component in

Quinnova Pharmaceuticals, a specialty pharmaceutical company, has received the FDA clearance for the company’s new product Neosalus Cream, a line extension to the previously launched Neosalus Foam, the

Germany-based biotechnology company Evotec has reported the results of a Phase II proof-of-concept study investigating the potential of EVT 302, a reversible and selective inhibitor of monoamine oxidase

GlobalChem 2009 was initiated by leaders at EPA and Capitol Hill, as well as industry and international experts to discuss on developments in chemical risk management policies in

Irving Weissman, director of Stanford’s Institute for Stem Cell Biology and Regenerative Medicine, said the SCNT technique is one way to create disease-specific human embryonic stem cell lines